elevation suggests contamination or mislabeled product) Clinical Research Findings A comprehensive safety and tolerability analysis evaluated approximately 900 participants across six randomized, double-blind, placebo-controlled trials conducted between 2001-2006
Contraindications and Drug Interactions Absolute contraindications include Wilsons Disease or other copper metabolism disorders (risk of dangerous copper accumulation), known copper allergy or hypersensitivity (risk of severe allergic reactions), and pregnancy/breastfeeding (no safety data available for systemic use)
896 More than half of these savings were attributed to reduced inpatient hospital costs
Typical dosages range from: 200 mcg to 500 mcg per day for minor injuries Up to 1,000 mcg per day for more serious cases Duration of therapy generally spans 2 to 4 weeks, though some protocols extend longer depending on the severity of the condition
This multi-pronged approach may be especially beneficial for patients who have not achieved satisfactory results with single-agent therapies
ConsumerLab.com answer explains